IBT
ALXN
International Biotechnology Trust’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-99,241
| Closed | -$15.5M | – | 59 |
|
|
2020
Q4 | $15.5M | Buy |
99,241
+24,000
| +32% | +$3.75M | 4.23% | 10 |
|
|
2020
Q3 | $8.6M | Sell |
75,241
-13,000
| -15% | -$1.49M | 2.78% | 14 |
|
|
2020
Q2 | $9.81M | Buy |
88,241
+14,600
| +20% | +$1.62M | 3.26% | 13 |
|
|
2020
Q1 | $6.61M | Sell |
73,641
-12,500
| -15% | -$1.12M | 3.01% | 13 |
|
|
2019
Q4 | $9.31M | Sell |
86,141
-16,000
| -16% | -$1.73M | 3.35% | 10 |
|
|
2019
Q3 | $10M | Buy |
102,141
+3,500
| +4% | +$343K | 4.62% | 7 |
|
|
2019
Q2 | $12.9M | Buy |
98,641
+25,000
| +34% | +$3.27M | 4.79% | 5 |
|
|
2019
Q1 | $9.95M | Hold |
73,641
| – | – | 3.68% | 5 |
|
|
2018
Q4 | $5.63M | Sell |
73,641
-8,000
| -10% | -$612K | 3.5% | 11 |
|
|
2018
Q3 | $8.7M | Hold |
81,641
| – | – | 4.13% | 8 |
|
|
2018
Q2 | $10.1M | Buy |
81,641
+9,200
| +13% | +$1.14M | 3.89% | 8 |
|
|
2018
Q1 | $8.07M | Hold |
72,441
| – | – | 3.15% | 12 |
|
|
2017
Q4 | $8.67M | Sell |
72,441
-19,700
| -21% | -$2.36M | 3.05% | 10 |
|
|
2017
Q3 | $12.9M | Sell |
92,141
-4,500
| -5% | -$631K | 5.03% | 5 |
|
|
2017
Q2 | $11.8M | Sell |
96,641
-28,000
| -22% | -$3.41M | 4.47% | 5 |
|
|
2017
Q1 | $15.1M | Sell |
124,641
-9,200
| -7% | -$1.12M | 5.78% | 5 |
|
|
2016
Q4 | $16.4M | Buy |
+133,841
| New | +$16.4M | 7.38% | 3 |
|